Health and Healthcare

AbbVie : ABBV

All AbbVie Articles

565 Articles

Chris Lange | Nov 11, 2015 at 8:15 AM EST

Short Sellers Continue to Decrease Bets in Major Pharma

The short interest data have been released for the October 30 settlement date, and for most of the selected pharmaceutical…

Lee Jackson | Nov 10, 2015 at 10:35 AM EST

Top Technology Stock Removed From Jefferies Franchise Picks List

Buying stocks such as these, with solid growth potential and paying dividends higher than the 10-year Treasury debt, makes good…

Jon C. Ogg | Nov 10, 2015 at 8:55 AM EST

Top Analyst Upgrades and Downgrades: AbbVie, Apple, Autodesk, JD.com, CyberArk, Dean Foods, Disney and More

Tuesday's top analyst upgrades, downgrades and initiations include AbbVie, Apple, Autodesk, JD.com, CyberArk, Dean Foods and Walt Disney.

Chris Lange | Oct 30, 2015 at 8:40 AM EDT

AbbVie Soars on Solid Earnings and Guidance

AbbVie reported better-than-expected third-quarter financial results before the markets opened on Friday.

Chris Lange | Oct 29, 2015 at 12:25 PM EDT

What to Look For in AbbVie Earnings

AbbVie is expected to report its third-quarter financial results before the markets open on Friday.

Chris Lange | Oct 27, 2015 at 12:55 PM EDT

What to Look For in Gilead Earnings

Gilead Sciences is set to report its third-quarter financial results after the markets close on Thursday.

Chris Lange | Oct 27, 2015 at 9:05 AM EDT

Short Sellers Have Mixed Views on Major Pharma

The October 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Lee Jackson | Oct 27, 2015 at 8:55 AM EDT

4 Top Jefferies Value Stocks to Buy This Week

Each week we cover the new value calls from the analysts at Jefferies, and more and more, some of the…

Chris Lange | Oct 24, 2015 at 9:40 AM EDT

8 BioPharma Movers That Cannot Be Ignored

These biotech stocks 24/7 Wall St. has picked stood out from the rest with at least 25% gains over the…

Jon C. Ogg | Oct 23, 2015 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, Alphabet, Amazon, Apple, Microsoft, Pandora, McDonald’s, Many More

Friday's top analyst upgrades, downgrades and initiations include AbbVie, Alphabet, Amazon.com, American Electric Power, Apple, Microsoft, Pandora Media and McDonald's.

Chris Lange | Oct 22, 2015 at 4:31 PM EDT

How FDA Warning Could Spell Disaster for AbbVie and Opportunity for Gilead

ThinkstockThe U.S. Food and Drug Administration (FDA) issued a warning that hepatitis C treatments, Viekira Pak and Technivie, can cause…

Lee Jackson | Oct 12, 2015 at 10:15 AM EDT

Jefferies Franchise Pick Stocks to Buy That Also Pay Big Dividends

These Jefferies Franchise picks with solid dividends are perfect for long-term accounts that like to employ a buy-and-hold strategy.

Chris Lange | Oct 12, 2015 at 9:25 AM EDT

Short Sellers Become More Selective on Major Pharma

The September 30 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Lee Jackson | Oct 5, 2015 at 8:20 AM EDT

Credit Suisse Adds Blue Chip Dividend Stocks to Prestigious Top Picks List

Credit Suisse is adding some top conservative dividend-paying stocks to its Top Picks list, and that is right in line…

Chris Lange | Sep 25, 2015 at 8:40 AM EDT

Short Sellers Boost Positions in Major Pharma

The September 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

1 … 30 31 32 33 34 … 38

AbbVie : ABBV

All AbbVie Articles

Short Sellers Continue to Decrease Bets in Major Pharma

Top Technology Stock Removed From Jefferies Franchise Picks List

Top Analyst Upgrades and Downgrades: AbbVie, Apple, Autodesk, JD.com, CyberArk, Dean Foods, Disney and More

AbbVie Soars on Solid Earnings and Guidance

What to Look For in AbbVie Earnings

What to Look For in Gilead Earnings

Short Sellers Have Mixed Views on Major Pharma

4 Top Jefferies Value Stocks to Buy This Week

8 BioPharma Movers That Cannot Be Ignored

Top Analyst Upgrades and Downgrades: AbbVie, Alphabet, Amazon, Apple, Microsoft, Pandora, McDonald’s, Many More

How FDA Warning Could Spell Disaster for AbbVie and Opportunity for Gilead

Jefferies Franchise Pick Stocks to Buy That Also Pay Big Dividends

Short Sellers Become More Selective on Major Pharma

Credit Suisse Adds Blue Chip Dividend Stocks to Prestigious Top Picks List

Short Sellers Boost Positions in Major Pharma

Ripple’s $1.25 Billion Hidden Road Acquisition: One Year On, What’s Changed?

Why Your 401(k) Could Trigger a Tax Bomb in Retirement (And What to Do Now)

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Why Your 401(k) Could Trigger a Tax Bomb in Retirement (And What to Do Now)

"Did you buy It from the mob?": Dave Ramsey hosts floored by 21-year-old's 30% truck loan

Ripple’s $1.25 Billion Hidden Road Acquisition: One Year On, What’s Changed?

Why Your 401(k) Could Trigger a Tax Bomb in Retirement (And What to Do Now)

AbbVie : ABBV

All AbbVie Articles

Short Sellers Continue to Decrease Bets in Major Pharma

Top Technology Stock Removed From Jefferies Franchise Picks List

Top Analyst Upgrades and Downgrades: AbbVie, Apple, Autodesk, JD.com, CyberArk, Dean Foods, Disney and More

AbbVie Soars on Solid Earnings and Guidance

What to Look For in AbbVie Earnings

What to Look For in Gilead Earnings

Short Sellers Have Mixed Views on Major Pharma

4 Top Jefferies Value Stocks to Buy This Week

8 BioPharma Movers That Cannot Be Ignored

Top Analyst Upgrades and Downgrades: AbbVie, Alphabet, Amazon, Apple, Microsoft, Pandora, McDonald’s, Many More

How FDA Warning Could Spell Disaster for AbbVie and Opportunity for Gilead

Jefferies Franchise Pick Stocks to Buy That Also Pay Big Dividends

Short Sellers Become More Selective on Major Pharma

Credit Suisse Adds Blue Chip Dividend Stocks to Prestigious Top Picks List

Short Sellers Boost Positions in Major Pharma

Ripple’s $1.25 Billion Hidden Road Acquisition: One Year On, What’s Changed?

Why Your 401(k) Could Trigger a Tax Bomb in Retirement (And What to Do Now)

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Featured Reads

Why Your 401(k) Could Trigger a Tax Bomb in Retirement (And What to Do Now)

"Did you buy It from the mob?": Dave Ramsey hosts floored by 21-year-old's 30% truck loan